1163141-57-8

Basic information

• Product Name: 3-Cyano-5-hydroxybenzoic acid
• Synonyms: 3-Cyano-5-hydroxybenzoic acid
• CAS NO: 1163141-57-8
• Molecular Weight: 163.133
• Mol File: 1163141-57-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-Cyano-5-hydroxybenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Cyano-5-hydroxybenzoic acid(1163141-57-8)
• EPA Substance Registry System: 3-Cyano-5-hydroxybenzoic acid(1163141-57-8)

Safety Data

• Hazardous Substances Data: 1163141-57-8(Hazardous Substances Data)

Upstream product

• 140472-69-1 3-bromo-5-hydroxy-benzoic acid 

Downstream Products

• 453565-76-9 methyl 3-cyano-5-hydroxy-benzoate 
• 661458-28-2 methyl 3-cyano-5-methoxybenzoate 

Relevant articles and documents

FLUOROPHENYL PYRAZOL COMPOUNDS

The present invention provides a compound of the Formula: wherein X is selected from the group consisting of, R is selected from the group consisting of H and CH3; R1 is selected from the group consisting of H, CH3, F, Cl, OCH3, C(O)OH, C(O)NH2 or a pharmaceutically acceptable salt thereof.

TETRAHYDROCYCLOPENTA[B]INDOL-3-YL CARBOXYLIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

The present invention relates to certain (1,2,4-oxadiazol-3-yl)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl carboxylic acid derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, microbial infections or diseases and viral infections or diseases.